583 reports of this reaction
4.3% of all BINIMETINIB reports
#4 most reported adverse reaction
FATIGUE is the #4 most commonly reported adverse reaction for BINIMETINIB, manufactured by Array BioPharma Inc.. There are 583 FDA adverse event reports linking BINIMETINIB to FATIGUE. This represents approximately 4.3% of all 13,446 adverse event reports for this drug.
Patients taking BINIMETINIB who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among BINIMETINIB users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for BINIMETINIB:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 583 FDA reports for BINIMETINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.3% of all adverse event reports for BINIMETINIB, making it a notable side effect.
If you experience fatigue while taking BINIMETINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.